nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A5—Estradiol—osteoporosis	0.0877	0.162	CbGbCtD
Dutasteride—CYP3A4—Estropipate—osteoporosis	0.0824	0.152	CbGbCtD
Dutasteride—CYP3A4—Calcitriol—osteoporosis	0.0824	0.152	CbGbCtD
Dutasteride—CYP3A4—Ergocalciferol—osteoporosis	0.0658	0.122	CbGbCtD
Dutasteride—CYP3A4—Raloxifene—osteoporosis	0.055	0.101	CbGbCtD
Dutasteride—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0531	0.0979	CbGbCtD
Dutasteride—CYP3A4—Cholecalciferol—osteoporosis	0.0424	0.0783	CbGbCtD
Dutasteride—CYP3A4—Conjugated Estrogens—osteoporosis	0.039	0.0719	CbGbCtD
Dutasteride—CYP3A4—Estradiol—osteoporosis	0.0342	0.0631	CbGbCtD
Dutasteride—Breast swelling—Estropipate—osteoporosis	0.0266	0.0748	CcSEcCtD
Dutasteride—Breast swelling—Conjugated Estrogens—osteoporosis	0.0176	0.0495	CcSEcCtD
Dutasteride—Nipple pain—Estradiol—osteoporosis	0.0168	0.0473	CcSEcCtD
Dutasteride—Breast swelling—Estradiol—osteoporosis	0.014	0.0396	CcSEcCtD
Dutasteride—Prostate cancer—Zoledronate—osteoporosis	0.0119	0.0336	CcSEcCtD
Dutasteride—Breast tenderness—Estropipate—osteoporosis	0.0102	0.0288	CcSEcCtD
Dutasteride—Breast cancer—Estropipate—osteoporosis	0.00913	0.0257	CcSEcCtD
Dutasteride—SRD5A1—Androgen biosynthesis—POMC—osteoporosis	0.00901	0.0873	CbGpPWpGaD
Dutasteride—SRD5A2—Androgen biosynthesis—POMC—osteoporosis	0.00901	0.0873	CbGpPWpGaD
Dutasteride—Breast tenderness—Ethinyl Estradiol—osteoporosis	0.00829	0.0233	CcSEcCtD
Dutasteride—Breast cancer—Pamidronate—osteoporosis	0.00686	0.0193	CcSEcCtD
Dutasteride—Breast tenderness—Conjugated Estrogens—osteoporosis	0.00675	0.019	CcSEcCtD
Dutasteride—Breast cancer—Zoledronate—osteoporosis	0.00627	0.0177	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.00623	0.0604	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.00623	0.0604	CbGpPWpGaD
Dutasteride—Depressed mood—Ethinyl Estradiol—osteoporosis	0.00604	0.017	CcSEcCtD
Dutasteride—Breast cancer—Conjugated Estrogens—osteoporosis	0.00603	0.017	CcSEcCtD
Dutasteride—Loss of libido—Ethinyl Estradiol—osteoporosis	0.00585	0.0165	CcSEcCtD
Dutasteride—Breast tenderness—Estradiol—osteoporosis	0.00541	0.0152	CcSEcCtD
Dutasteride—Breast enlargement—Estropipate—osteoporosis	0.00514	0.0145	CcSEcCtD
Dutasteride—Breast cancer—Estradiol—osteoporosis	0.00483	0.0136	CcSEcCtD
Dutasteride—Breast enlargement—Ethinyl Estradiol—osteoporosis	0.00416	0.0117	CcSEcCtD
Dutasteride—Neoplasm malignant—Estropipate—osteoporosis	0.0039	0.011	CcSEcCtD
Dutasteride—Tenderness—Estropipate—osteoporosis	0.00382	0.0108	CcSEcCtD
Dutasteride—Breast pain—Estropipate—osteoporosis	0.00382	0.0108	CcSEcCtD
Dutasteride—Loss of libido—Estradiol—osteoporosis	0.00382	0.0107	CcSEcCtD
Dutasteride—Neoplasm malignant—Raloxifene—osteoporosis	0.00378	0.0106	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.00374	0.0363	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.00374	0.0363	CbGpPWpGaD
Dutasteride—Breast pain—Raloxifene—osteoporosis	0.0037	0.0104	CcSEcCtD
Dutasteride—Tenderness—Raloxifene—osteoporosis	0.0037	0.0104	CcSEcCtD
Dutasteride—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00367	0.0356	CbGpPWpGaD
Dutasteride—Neoplasm malignant—Calcitriol—osteoporosis	0.00366	0.0103	CcSEcCtD
Dutasteride—Breast enlargement—Conjugated Estrogens—osteoporosis	0.00339	0.00956	CcSEcCtD
Dutasteride—Breast pain—Ethinyl Estradiol—osteoporosis	0.00309	0.00872	CcSEcCtD
Dutasteride—Neoplasm—Estropipate—osteoporosis	0.00301	0.00848	CcSEcCtD
Dutasteride—Neoplasm malignant—Pamidronate—osteoporosis	0.00293	0.00826	CcSEcCtD
Dutasteride—Hyperaesthesia—Zoledronate—osteoporosis	0.00291	0.00821	CcSEcCtD
Dutasteride—Breast enlargement—Estradiol—osteoporosis	0.00272	0.00765	CcSEcCtD
Dutasteride—Neoplasm malignant—Zoledronate—osteoporosis	0.00268	0.00754	CcSEcCtD
Dutasteride—Neoplasm malignant—Conjugated Estrogens—osteoporosis	0.00258	0.00726	CcSEcCtD
Dutasteride—Breast pain—Conjugated Estrogens—osteoporosis	0.00252	0.00711	CcSEcCtD
Dutasteride—Tenderness—Conjugated Estrogens—osteoporosis	0.00252	0.00711	CcSEcCtD
Dutasteride—Libido decreased—Calcitriol—osteoporosis	0.00245	0.0069	CcSEcCtD
Dutasteride—Neoplasm—Ethinyl Estradiol—osteoporosis	0.00244	0.00688	CcSEcCtD
Dutasteride—Neoplasm—Risedronate—osteoporosis	0.00238	0.00671	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Calcitriol—osteoporosis	0.00225	0.00634	CcSEcCtD
Dutasteride—Hyperaesthesia—Estradiol—osteoporosis	0.00224	0.00632	CcSEcCtD
Dutasteride—Breast disorder—Estropipate—osteoporosis	0.00219	0.00616	CcSEcCtD
Dutasteride—Breast disorder—Raloxifene—osteoporosis	0.00212	0.00596	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00212	0.0205	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00212	0.0205	CbGpPWpGaD
Dutasteride—Libido decreased—Ethinyl Estradiol—osteoporosis	0.00211	0.00595	CcSEcCtD
Dutasteride—Breast disorder—Ibandronate—osteoporosis	0.0021	0.0059	CcSEcCtD
Dutasteride—Neoplasm—Zoledronate—osteoporosis	0.00207	0.00582	CcSEcCtD
Dutasteride—Neoplasm malignant—Estradiol—osteoporosis	0.00206	0.00581	CcSEcCtD
Dutasteride—Breast pain—Estradiol—osteoporosis	0.00202	0.00569	CcSEcCtD
Dutasteride—Tenderness—Estradiol—osteoporosis	0.00202	0.00569	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00201	0.0194	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00201	0.0194	CbGpPWpGaD
Dutasteride—Neoplasm—Conjugated Estrogens—osteoporosis	0.00199	0.00561	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Ethinyl Estradiol—osteoporosis	0.00194	0.00548	CcSEcCtD
Dutasteride—Cardiac failure—Pamidronate—osteoporosis	0.00186	0.00524	CcSEcCtD
Dutasteride—Breast disorder—Ethinyl Estradiol—osteoporosis	0.00177	0.00499	CcSEcCtD
Dutasteride—Breast disorder—Risedronate—osteoporosis	0.00173	0.00487	CcSEcCtD
Dutasteride—Neoplasm—Estradiol—osteoporosis	0.00159	0.00449	CcSEcCtD
Dutasteride—Gynaecomastia—Estradiol—osteoporosis	0.00158	0.00444	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00156	0.0151	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00156	0.0151	CbGpPWpGaD
Dutasteride—Hypersensitivity—Calcium Acetate—osteoporosis	0.00154	0.00434	CcSEcCtD
Dutasteride—Angioedema—Etidronic acid—osteoporosis	0.00154	0.00433	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00152	0.0147	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00152	0.0147	CbGpPWpGaD
Dutasteride—Immune system disorder—Estropipate—osteoporosis	0.00151	0.00426	CcSEcCtD
Dutasteride—Pruritus—Calcium Acetate—osteoporosis	0.00148	0.00417	CcSEcCtD
Dutasteride—Mental disorder—Estropipate—osteoporosis	0.00147	0.00413	CcSEcCtD
Dutasteride—Immune system disorder—Ibandronate—osteoporosis	0.00145	0.00408	CcSEcCtD
Dutasteride—Breast disorder—Conjugated Estrogens—osteoporosis	0.00144	0.00407	CcSEcCtD
Dutasteride—Mental disorder—Ibandronate—osteoporosis	0.00141	0.00396	CcSEcCtD
Dutasteride—Dizziness—Calcium Acetate—osteoporosis	0.00138	0.0039	CcSEcCtD
Dutasteride—Libido decreased—Estradiol—osteoporosis	0.00138	0.00388	CcSEcCtD
Dutasteride—Angioedema—Estropipate—osteoporosis	0.00133	0.00375	CcSEcCtD
Dutasteride—Angioedema—Alendronate—osteoporosis	0.00131	0.00369	CcSEcCtD
Dutasteride—Angioedema—Ibandronate—osteoporosis	0.00128	0.00359	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Estradiol—osteoporosis	0.00127	0.00357	CcSEcCtD
Dutasteride—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00122	0.00345	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00122	0.0118	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00122	0.0118	CbGpPWpGaD
Dutasteride—Immune system disorder—Risedronate—osteoporosis	0.00119	0.00336	CcSEcCtD
Dutasteride—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00119	0.00335	CcSEcCtD
Dutasteride—Mental disorder—Risedronate—osteoporosis	0.00116	0.00326	CcSEcCtD
Dutasteride—Breast disorder—Estradiol—osteoporosis	0.00116	0.00326	CcSEcCtD
Dutasteride—Immune system disorder—Pamidronate—osteoporosis	0.00114	0.0032	CcSEcCtD
Dutasteride—Urticaria—Etidronic acid—osteoporosis	0.00109	0.00307	CcSEcCtD
Dutasteride—Angioedema—Ethinyl Estradiol—osteoporosis	0.00108	0.00304	CcSEcCtD
Dutasteride—Angioedema—Risedronate—osteoporosis	0.00105	0.00296	CcSEcCtD
Dutasteride—Immune system disorder—Zoledronate—osteoporosis	0.00104	0.00292	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.00103	0.01	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.00103	0.01	CbGpPWpGaD
Dutasteride—Hypersensitivity—Etidronic acid—osteoporosis	0.00101	0.00285	CcSEcCtD
Dutasteride—Mental disorder—Zoledronate—osteoporosis	0.00101	0.00283	CcSEcCtD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.001	0.00971	CbGpPWpGaD
Dutasteride—Angioedema—Pamidronate—osteoporosis	0.001	0.00282	CcSEcCtD
Dutasteride—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000998	0.00281	CcSEcCtD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000989	0.00958	CbGpPWpGaD
Dutasteride—Pruritus—Etidronic acid—osteoporosis	0.000972	0.00274	CcSEcCtD
Dutasteride—Mental disorder—Conjugated Estrogens—osteoporosis	0.000968	0.00273	CcSEcCtD
Dutasteride—Urticaria—Estropipate—osteoporosis	0.000944	0.00266	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—FDPS—osteoporosis	0.000942	0.00913	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PKM—osteoporosis	0.000942	0.00913	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PKM—osteoporosis	0.000942	0.00913	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—FDPS—osteoporosis	0.000942	0.00913	CbGpPWpGaD
Dutasteride—Urticaria—Alendronate—osteoporosis	0.00093	0.00262	CcSEcCtD
Dutasteride—Angioedema—Zoledronate—osteoporosis	0.000913	0.00257	CcSEcCtD
Dutasteride—Urticaria—Ibandronate—osteoporosis	0.000905	0.00255	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—PGLS—osteoporosis	0.000893	0.00866	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GPD2—osteoporosis	0.000893	0.00866	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GPD2—osteoporosis	0.000893	0.00866	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PGLS—osteoporosis	0.000893	0.00866	CbGpPWpGaD
Dutasteride—Urticaria—Calcitriol—osteoporosis	0.000886	0.0025	CcSEcCtD
Dutasteride—Angioedema—Conjugated Estrogens—osteoporosis	0.000879	0.00248	CcSEcCtD
Dutasteride—Hypersensitivity—Estropipate—osteoporosis	0.000876	0.00247	CcSEcCtD
Dutasteride—Rash—Etidronic acid—osteoporosis	0.000866	0.00244	CcSEcCtD
Dutasteride—Dermatitis—Etidronic acid—osteoporosis	0.000865	0.00244	CcSEcCtD
Dutasteride—Hypersensitivity—Alendronate—osteoporosis	0.000862	0.00243	CcSEcCtD
Dutasteride—Pruritus—Estropipate—osteoporosis	0.000841	0.00237	CcSEcCtD
Dutasteride—Hypersensitivity—Ibandronate—osteoporosis	0.00084	0.00237	CcSEcCtD
Dutasteride—Pruritus—Alendronate—osteoporosis	0.000828	0.00233	CcSEcCtD
Dutasteride—Hypersensitivity—Calcitriol—osteoporosis	0.000822	0.00232	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—ATIC—osteoporosis	0.000817	0.00792	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PNP—osteoporosis	0.000817	0.00792	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ATIC—osteoporosis	0.000817	0.00792	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PNP—osteoporosis	0.000817	0.00792	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000812	0.00787	CbGpPWpGaD
Dutasteride—Pruritus—Ibandronate—osteoporosis	0.000806	0.00227	CcSEcCtD
Dutasteride—Immune system disorder—Estradiol—osteoporosis	0.000799	0.00225	CcSEcCtD
Dutasteride—Pruritus—Calcitriol—osteoporosis	0.000789	0.00222	CcSEcCtD
Dutasteride—Dizziness—Estropipate—osteoporosis	0.000786	0.00221	CcSEcCtD
Dutasteride—Mental disorder—Estradiol—osteoporosis	0.000775	0.00218	CcSEcCtD
Dutasteride—Dizziness—Alendronate—osteoporosis	0.000774	0.00218	CcSEcCtD
Dutasteride—Urticaria—Ethinyl Estradiol—osteoporosis	0.000765	0.00216	CcSEcCtD
Dutasteride—Dizziness—Raloxifene—osteoporosis	0.000761	0.00214	CcSEcCtD
Dutasteride—Dizziness—Ibandronate—osteoporosis	0.000754	0.00212	CcSEcCtD
Dutasteride—Rash—Estropipate—osteoporosis	0.000749	0.00211	CcSEcCtD
Dutasteride—Dermatitis—Estropipate—osteoporosis	0.000749	0.00211	CcSEcCtD
Dutasteride—Urticaria—Risedronate—osteoporosis	0.000746	0.0021	CcSEcCtD
Dutasteride—Rash—Alendronate—osteoporosis	0.000738	0.00208	CcSEcCtD
Dutasteride—Dermatitis—Alendronate—osteoporosis	0.000737	0.00208	CcSEcCtD
Dutasteride—Rash—Raloxifene—osteoporosis	0.000726	0.00204	CcSEcCtD
Dutasteride—Dermatitis—Raloxifene—osteoporosis	0.000725	0.00204	CcSEcCtD
Dutasteride—Rash—Ibandronate—osteoporosis	0.000719	0.00202	CcSEcCtD
Dutasteride—Dermatitis—Ibandronate—osteoporosis	0.000718	0.00202	CcSEcCtD
Dutasteride—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00071	0.002	CcSEcCtD
Dutasteride—Angioedema—Estradiol—osteoporosis	0.000704	0.00198	CcSEcCtD
Dutasteride—Rash—Calcitriol—osteoporosis	0.000703	0.00198	CcSEcCtD
Dutasteride—Dermatitis—Calcitriol—osteoporosis	0.000703	0.00198	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—CA2—osteoporosis	0.000695	0.00673	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—OXCT1—osteoporosis	0.000695	0.00673	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—OXCT1—osteoporosis	0.000695	0.00673	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CA2—osteoporosis	0.000695	0.00673	CbGpPWpGaD
Dutasteride—Hypersensitivity—Risedronate—osteoporosis	0.000692	0.00195	CcSEcCtD
Dutasteride—Pruritus—Ethinyl Estradiol—osteoporosis	0.000682	0.00192	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—MGLL—osteoporosis	0.000677	0.00656	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—MGLL—osteoporosis	0.000677	0.00656	CbGpPWpGaD
Dutasteride—Pruritus—Risedronate—osteoporosis	0.000665	0.00187	CcSEcCtD
Dutasteride—Hypersensitivity—Pamidronate—osteoporosis	0.000658	0.00185	CcSEcCtD
Dutasteride—Urticaria—Zoledronate—osteoporosis	0.000648	0.00183	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000638	0.00619	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000638	0.00619	CbGpPWpGaD
Dutasteride—Dizziness—Ethinyl Estradiol—osteoporosis	0.000637	0.00179	CcSEcCtD
Dutasteride—Pruritus—Pamidronate—osteoporosis	0.000632	0.00178	CcSEcCtD
Dutasteride—Urticaria—Conjugated Estrogens—osteoporosis	0.000624	0.00176	CcSEcCtD
Dutasteride—Dizziness—Risedronate—osteoporosis	0.000621	0.00175	CcSEcCtD
Dutasteride—Rash—Ethinyl Estradiol—osteoporosis	0.000607	0.00171	CcSEcCtD
Dutasteride—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000607	0.00171	CcSEcCtD
Dutasteride—Hypersensitivity—Zoledronate—osteoporosis	0.000601	0.00169	CcSEcCtD
Dutasteride—Rash—Risedronate—osteoporosis	0.000592	0.00167	CcSEcCtD
Dutasteride—Dermatitis—Risedronate—osteoporosis	0.000592	0.00167	CcSEcCtD
Dutasteride—Dizziness—Pamidronate—osteoporosis	0.00059	0.00166	CcSEcCtD
Dutasteride—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000586	0.00568	CbGpPWpGaD
Dutasteride—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000579	0.00163	CcSEcCtD
Dutasteride—Pruritus—Zoledronate—osteoporosis	0.000577	0.00163	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—IDH2—osteoporosis	0.000576	0.00558	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—IDH2—osteoporosis	0.000576	0.00558	CbGpPWpGaD
Dutasteride—Rash—Pamidronate—osteoporosis	0.000563	0.00159	CcSEcCtD
Dutasteride—Dermatitis—Pamidronate—osteoporosis	0.000562	0.00158	CcSEcCtD
Dutasteride—Pruritus—Conjugated Estrogens—osteoporosis	0.000556	0.00157	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—CYP27A1—osteoporosis	0.000541	0.00524	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP27A1—osteoporosis	0.000541	0.00524	CbGpPWpGaD
Dutasteride—Dizziness—Zoledronate—osteoporosis	0.000539	0.00152	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—ACP5—osteoporosis	0.000526	0.0051	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ACP5—osteoporosis	0.000526	0.0051	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000526	0.0051	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.00052	0.00504	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.00052	0.00504	CbGpPWpGaD
Dutasteride—Dizziness—Conjugated Estrogens—osteoporosis	0.000519	0.00146	CcSEcCtD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000519	0.00503	CbGpPWpGaD
Dutasteride—Rash—Zoledronate—osteoporosis	0.000514	0.00145	CcSEcCtD
Dutasteride—Dermatitis—Zoledronate—osteoporosis	0.000514	0.00145	CcSEcCtD
Dutasteride—Urticaria—Estradiol—osteoporosis	0.000499	0.00141	CcSEcCtD
Dutasteride—Rash—Conjugated Estrogens—osteoporosis	0.000495	0.00139	CcSEcCtD
Dutasteride—Dermatitis—Conjugated Estrogens—osteoporosis	0.000495	0.00139	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—TPI1—osteoporosis	0.000489	0.00474	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—TPI1—osteoporosis	0.000489	0.00474	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000466	0.00451	CbGpPWpGaD
Dutasteride—Hypersensitivity—Estradiol—osteoporosis	0.000463	0.0013	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—P4HB—osteoporosis	0.00046	0.00446	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—P4HB—osteoporosis	0.00046	0.00446	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00046	0.00445	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GAPDH—osteoporosis	0.000452	0.00438	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GAPDH—osteoporosis	0.000452	0.00438	CbGpPWpGaD
Dutasteride—Pruritus—Estradiol—osteoporosis	0.000445	0.00125	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—RAP1A—osteoporosis	0.00044	0.00426	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—RAP1A—osteoporosis	0.00044	0.00426	CbGpPWpGaD
Dutasteride—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000439	0.00425	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	0.000431	0.00418	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000427	0.00413	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	0.000425	0.00412	CbGpPWpGaD
Dutasteride—Dizziness—Estradiol—osteoporosis	0.000416	0.00117	CcSEcCtD
Dutasteride—Rash—Estradiol—osteoporosis	0.000396	0.00112	CcSEcCtD
Dutasteride—Dermatitis—Estradiol—osteoporosis	0.000396	0.00112	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000384	0.00372	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000384	0.00372	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000378	0.00366	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ENO1—osteoporosis	0.000356	0.00345	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ENO1—osteoporosis	0.000356	0.00345	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PSMA5—osteoporosis	0.00035	0.0034	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PSMA2—osteoporosis	0.00035	0.0034	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PSMA5—osteoporosis	0.00035	0.0034	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PSMA2—osteoporosis	0.00035	0.0034	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000337	0.00326	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000316	0.00306	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000303	0.00293	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP19A1—osteoporosis	0.000284	0.00275	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP19A1—osteoporosis	0.000284	0.00275	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000256	0.00248	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000245	0.00237	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000241	0.00234	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ADCY5—osteoporosis	0.000232	0.00225	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ADCY5—osteoporosis	0.000232	0.00225	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GPX1—osteoporosis	0.000231	0.00224	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GPX1—osteoporosis	0.000231	0.00224	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	0.000227	0.0022	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	0.000223	0.00217	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—MTHFR—osteoporosis	0.000214	0.00207	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—MTHFR—osteoporosis	0.000214	0.00207	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000201	0.00194	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000198	0.00192	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000198	0.00192	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—POMC—osteoporosis	0.000171	0.00166	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—POMC—osteoporosis	0.000171	0.00166	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000147	0.00142	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—POMC—osteoporosis	0.000136	0.00132	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PKM—osteoporosis	0.000128	0.00124	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—FDPS—osteoporosis	0.000128	0.00124	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PGLS—osteoporosis	0.000122	0.00118	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPD2—osteoporosis	0.000122	0.00118	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000119	0.00116	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PNP—osteoporosis	0.000111	0.00108	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ATIC—osteoporosis	0.000111	0.00108	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	0.000105	0.00102	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	0.000104	0.00101	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CA2—osteoporosis	9.47e-05	0.000918	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—OXCT1—osteoporosis	9.47e-05	0.000918	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MGLL—osteoporosis	9.23e-05	0.000894	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—IDH2—osteoporosis	7.85e-05	0.00076	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP27A1—osteoporosis	7.38e-05	0.000715	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ACP5—osteoporosis	7.18e-05	0.000695	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—TPI1—osteoporosis	6.67e-05	0.000647	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—POMC—osteoporosis	6.33e-05	0.000614	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—P4HB—osteoporosis	6.27e-05	0.000608	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GAPDH—osteoporosis	6.16e-05	0.000597	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—RAP1A—osteoporosis	6e-05	0.000581	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—FDPS—osteoporosis	5.97e-05	0.000579	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PKM—osteoporosis	5.97e-05	0.000579	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPD2—osteoporosis	5.66e-05	0.000549	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PGLS—osteoporosis	5.66e-05	0.000549	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ATIC—osteoporosis	5.18e-05	0.000502	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PNP—osteoporosis	5.18e-05	0.000502	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ENO1—osteoporosis	4.85e-05	0.00047	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PSMA2—osteoporosis	4.78e-05	0.000463	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PSMA5—osteoporosis	4.78e-05	0.000463	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CA2—osteoporosis	4.4e-05	0.000427	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—OXCT1—osteoporosis	4.4e-05	0.000427	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MGLL—osteoporosis	4.29e-05	0.000416	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP19A1—osteoporosis	3.88e-05	0.000376	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—IDH2—osteoporosis	3.65e-05	0.000354	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.43e-05	0.000332	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ACP5—osteoporosis	3.34e-05	0.000323	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ADCY5—osteoporosis	3.17e-05	0.000307	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPX1—osteoporosis	3.16e-05	0.000306	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TPI1—osteoporosis	3.1e-05	0.000301	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—P4HB—osteoporosis	2.92e-05	0.000283	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MTHFR—osteoporosis	2.91e-05	0.000282	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GAPDH—osteoporosis	2.86e-05	0.000277	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—RAP1A—osteoporosis	2.79e-05	0.00027	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—POMC—osteoporosis	2.33e-05	0.000226	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ENO1—osteoporosis	2.25e-05	0.000218	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PSMA2—osteoporosis	2.22e-05	0.000215	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PSMA5—osteoporosis	2.22e-05	0.000215	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.8e-05	0.000175	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ADCY5—osteoporosis	1.47e-05	0.000143	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPX1—osteoporosis	1.47e-05	0.000142	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MTHFR—osteoporosis	1.35e-05	0.000131	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—POMC—osteoporosis	1.08e-05	0.000105	CbGpPWpGaD
